J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - USFDA Inspection Of Company'S Manufacturing Facility - T20 At Panoli, Gujarat
USFDA inspection of Company's manufacturing facility - T20 at Panoli, Gujarat12-06-2023
12-06-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Submission of Information of loss of share certificates under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201509-06-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme31-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Transcript of Investors/Analysts call30-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Intimation Of Schedule Of Analysts/Institutional Investors Meet
Intimation of schedule of Analysts/Institutional investors meet26-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Intimation Of Record Date Pursuant To Regulation 42 Of The Securities & Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201526-05-2023
J B Chemicals & Pharmaceuticals Results Earnings Call for Q4FY23
Conference Call with J B Chemicals & Pharmaceuticals Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.25-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of Investors/analysts call with Management25-05-2023
JB Chemicals and Pharmaceuticals jumps 6% after strong Q4 numbers
During the March quarter, total revenue stood at Rs 762.3 crore, up 22 percent driven by strong performance and double-digit growth across all segments.25-05-2023
J.B.CHEMICALS & PHARMACEUTICALS LTD. - 506943 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 202325-05-2023